Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the company.

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.”

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to what's at the root of their illness, received a hopeful sign Thursday.

A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for vaccines.

The Trump administration is planning to drop recommendations that pregnant women, teenagers and children get Covid-19 vaccines as a matter of routine, according to people familiar with the matter.

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.